| 2922.43 | | Anthranilic acid and its salts: | | | | |
| 2922.43.10 | 00 | Products described in additional U.S. note 3 to section VI | kg | 6.5% | Free (A+,AU,BH, CA,CL,D,E,IL,J, JO,K,MA,MX, P) 2.9% (SG) | 15.4¢/kg + 50% |
| 2922.44.00 | 00 | Tilidine (INN) and its salts | kg | Free | | 15.4¢/kg + 45% |
| 2922.49.05 | 00 | ¢/- α-Aminobenzeneacetic acid; 2-Amino-3-chlorobenzoic acid, methyl ester | kg | Free | | 15.4¢/kg + 50% |
| 2922.49.10 | 00 | m-Aminobenzoic acid, technical; p-Aminobenzoic acid; 3,5-Diaminobenzoic acid; 2-Ethylamino-5-sulfobenzoic acid; 3-(N-Ethylanilino)propionic acid, methyl ester; β-( β-Methoxyethoxyethyl)-4-aminobenzoate; Methyl anthranilate; and l-Phenylalanine | kg | 5.8% | Free (A+,AU,BH, CA,CL,D,E,IL,J, JO,K,MA,MX, P,SG) | 15.4¢/kg + 39% |
| 2922.49.26 | 00 | Drugs | kg | 6.5% | Free (A+,AU,BH, CA,CL,D,E,IL,J, JO,K,MA,MX, P,SG) | 15.4¢/kg + 45% |
| 2922.49.30 | 00 | Products described in additional U.S. note 3 to section VI | kg | 6.5% | Free (A+,AU,BH, CA,CL,D,E,IL,J, JO,K,MA,MX, P) 2.9% (SG) | 15.4¢/kg + 50% |
| 2922.49.40 | | Amino acids | | 4.2% | Free (A,AU,BH,CA, CL,E,IL,J,JO, K,MA,MX, P,SG) | 25% |
| 2922.49.40 | 15 | l-Aspartic acid | kg | | | |
| 2922.49.60 | 00 | 3-Aminocrotonic acid, methyl ester; and ¢/- α-Amino-1,4-cyclohexadiene-1- acetic acid | kg | Free | | 25% |
| 2922.50 | | Amino-alcohol-phenols, amino-acid-phenols and other amino-compounds with oxygen function: | | | | |
| 2922.50.07 | 00 | 3,4-Diaminophenetole dihydrogen sulfate; 2-Nitro-5-[(2,3-dihydroxy)propoxy]-¢/methylaniline; 2-Nitro-5-(2-hydroxyethoxy)-N-methylaniline; 4-(2-Hydroethoxy)-1,3-phenylenediamine dihydrochloride; 3-Methoxy-4-[(2-hydroxyethyl)amino]nitro- benzene; 4-[(2-Hydroxyethyl)amino]-3-nitrophenol; and ¢/- α-Amino-4-hydroxybenzeneacetic acid (d(-)-p-Hydroxyphenylglycine) | kg | Free | | 15.4¢/kg + 50% |
| 2922.50.10 | 00 | dl-3-(3,4-Dihydroxyphenyl)alanine; N-Ethyl-N-(2-methoxycarbonylethyl)aniline; dl-Phenylephrine base; and Carbonic acid, methyl ester, diester with 2,2'-(m-tolylamino)diethanol (Toluidine carbonate) | kg | 5.8% | Free (A+,AU,BH, CA,CL,D,E,IL,J, JO,K,MA,MX, P,SG) | 15.4¢/kg + 39% |
| 2922.50.11 | 00 | Salts of d(-)-p-Hydroxyphenylglycine (¢/- α-Amino-4-hydroxybenzeneacetic acid) | kg | 6.5% | Free (A,AU,BH,CA, CL,E,IL,J,JO, MA,MX,P) 0.2¢/kg + 3.1% (SG) | 15.4¢/kg + 50% |
| 2922.50.13 | 00 | Drugs: | | | | |
| 2922.50.13 | 00 | Isoetharine hydrochloride; Isoxsuprine hydrochloride; Nylidrin hydrochloride; Phenylephrine hydrochloride; Salbutamol (Albuterol); and Terbutaline sulfate | kg | Free | | 15.4¢/kg + 47% |
| 2922.50.14 | 00 | Cardiovascular drugs | kg | 6.5% | Free (A+,AU,BH, CA,CL,D,E,IL,J, JO,K,MA,MX, P,SG) | 15.4¢/kg + 65% |
| 2922.50.17 | 00 | Dermatological agents and local anesthetics | kg | 6.5% | Free (A+,AU,BH, CA,CL,D,E,IL,J, JO,K,MA,MX, P,SG) | 15.4¢/kg + 51.5% |
| 2922.50.19 | 00 | Guaiacol derivatives | kg | 6.5% | Free (A,AU,BH,CA, CL,E,IL,J,JO, K,MA,MX, P,SG) | 15.4¢/kg + 79% |
| 2922.50.35 | 00 | Products described in additional U.S. note 3 to section VI | kg | 6.5% | Free (A+,AU,BH, CA,CL,D,E,IL,J, JO,K,MA,MX, P) 2.9% (SG) | 15.4¢/kg + 50% |
| 2923 | | Quaternary ammonium salts and hydroxides; lecithins and other phosphoaminolipids, whether or not chemically defined: | | | | |
| 2923.10.00 | 00 | Choline and its salts | kg | 3.7% | Free (A,AU,BH,CA, CL,E,IL,J,JO, K,MA,MX, P,SG) | 25% |
| 2923.20 | | Lecithins and other phosphoaminolipids: | | | | |
| 2923.20.10 | 00 | Purified egg phospholipids, pharmaceutical grade meeting requirements of the U.S. Food and Drug Administration, for use in intravenous fat emulsion | kg | Free | | 16.5¢/kg + 30% |
| 2924 | | Carboxyamide-function compounds; amide-function compounds of carbonic acid: | | | | |
Harmonized Tariff Schedule of the United States inquiry: 3203Ã
